TipRanks
Alnylam Pharmaceuticals (CH:DUL)
:DUL

Compare Alnylam Pharma (DUL) vs. Competitors

0 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Alnylam Pharma
CHF179.99
CHF28.35B
41.22
-10.71%
18 Buy
3 Hold
0 Sell
Strong Buy
Arrowhead Pharmaceuticals
$88.88
$9.36B
-29.32
96.12%
11 Buy
1 Hold
0 Sell
Strong Buy
BioMarin Pharmaceutical
$66.12
$11.59B
156.47
10.83%
17 Buy
5 Hold
0 Sell
Strong Buy
Ionis Pharmaceuticals
$63.57
$7.63B
-13.19
-28.46%
17 Buy
4 Hold
0 Sell
Strong Buy
Intellia Therapeutics
$13.51
$1.69B
-3.43
-28.90%
6 Buy
4 Hold
2 Sell
Moderate Buy
Crispr Therapeutics AG
$60.90
$5.41B
-11.39
-12.18%
8 Buy
5 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
CH:DUL
Alnylam Pharma
204.47
-24.52
-10.71%
ARWR
Arrowhead Pharmaceuticals
66.25
31.76
92.08%
BMRN
BioMarin Pharmaceutical
59.87
5.71
10.54%
IONS
Ionis Pharmaceuticals
45.89
-19.53
-29.85%
NTLA
Intellia Therapeutics
12.03
-5.24
-30.34%
CRSP
Crispr Therapeutics AG
56.00
-8.81
-13.59%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts